|
Special Delegation of the ICF-BSE College of Fellows
to Travel to China in April
A special delegation of the International College of Fellows, Biomaterials Science and Engineering (ICF-BSE) has been established to travel to China in April 2010 provide informal advice and guidance to successfully organize the 9th World Biomaterials Congress, to be held in June 2012 in Chengdu.
The Fellows Delegation will also meet with Chinese Fellows to promote cooperation and an international Fellows exchange.
More details regarding the event will be announced.
We welcome the newest members of the ICF-BSE:
Mauli Agrawal
Mitsuru Akashi
Laurence Bordenave
Lisa Brannon-Peppas
Joost de Bruijn
Jan Chlopek
Bum-Koo Cho
I-Ming Chu
Jong-Pyung Chung
Lutz Claes
Arthur (Art) Coury
Fuzhai Cui
Guy Daculsi
Avi Domb
Eugene Goldberg
David Grainger
Dirk Grijpma
P. (Thilak) Gunatillake
Hoon Han
Takao Hanawa
|
Yoshiro Hayashi
Ging-Ho Hsiue
Nan Huang
Lynn L.-H. Huang
Seo-Young Jeong
Lynne Jones
Inn-Kyu Kang
Minna Kellomaki
Dae-Joon Kim
Kyo-Han Kim
Akio Kishida
Ivars Knets
Martine LaBerge
Doo-Sung Lee
Yang Leng
Jui-Che Lin
Andrew Lloyd
Mizuo Maeda
Anne Meyer
Ajit Nair |
Katsuhiko Nakamae
Paolo Netti
Dong-Kyun Rah
Chandra P Sharma
Molly Shoichet
Paulette Spencer
Hsing-Wen Sung
Yasuhiko Tabata
Maria Cristina Tanzi
Pentti Tengvall
Hasan Uludag
William Wagner
Yingjun Wang
Kimberly (Kim) Woodhouse
Kimihiro Yamashita
Heimo Ylanen
Takayuki Yoneyama
Nobuhiko Yui
|
The ICF-BSE College of Fellows Special Session Programme at the 2008 World Biomaterials Congress, Amsterdam
 Critical changes in biomaterials science:
Presented on behalf of the ICF-BSE
Steering Committee.
Joachim Kohn, Chair
|
 Biological Interactions at the Nanoscale:
How far can we go in mimicking nature?
Buddy Ratner |
 Twenty-first century biological methods
in biomaterials research.
Peter Revell |
 Beyond the foreign body response:
Understanding the mechanism of the
host response to biomaterial implants.
Michael Sefton |
The Debate:
 Topic:
This House Believes that the Preclinical Testing
of New Biomaterials is a Waste of Time.
Moderated by: David Williams
Every biomaterial introduced into commerce and clinical practice has to be assessed for biological safety, typically through a series of pre-clinical in vitro and in vivo procedures, for example those promulgated through ISO 10993. However, there is very good evidence to show that neither in vitro or in vivo tests are predictive of clinical performance and that many materials that pass the tests ultimately fail in some applications, whilst others that fail the test may have posed no risk to patients.
This debate, following the traditional format of debates, included arguments for and against the proposition, two from each side. No visual aids were used, the speakers were required to keep exactly to time. |
Debaters:
 David Grainger
USA
For the Motion
First Proposer |
 Peter Zilla
South Africa
Against the Motion
First Opposer
|
| |
|
 Sarah Cartmell
UK
For the Motion
Second Proposer |
 Tom Barker
USA
Against the Motion
Second Opposer
|
|
|
